Technical Analysis for CREO - Creo Medical Group Plc

Grade Last Price % Change Price Change
D 197.7 -0.40% -0.80
CREO closed down 1.73 percent on Tuesday, May 11, 2021, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical CREO trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction -0.40%
NR7 Range Contraction -0.40%
NR7-2 Range Contraction -0.40%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.13%
Narrow Range Bar Range Contraction -2.13%
NR7 Range Contraction -2.13%
Multiple of Ten Bullish Other -2.13%
Slingshot Bearish Bearish Swing Setup -1.15%
Narrow Range Bar Range Contraction -1.15%
Lower Bollinger Band Walk Weakness -1.15%
Older End-of-Day Signals for CREO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support about 4 hours ago
200 DMA Support about 4 hours ago
Down 3% about 4 hours ago
Down 2% about 4 hours ago
Fell Below Lower Bollinger Band about 4 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Creo Medical Group Plc Description

Creo Medical Group plc is a United Kingdom-based medical device company. The Company focuses on the field of surgical endoscopy. The Company focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer. The Company has developed CROMA, which is an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. The Company's surgical system CROMA combines bipolar radiofrequency for localized cutting and microwave energy for controlled coagulation, which provides physicians with simplified and controlled surgical solutions. The Company's pipeline portfolio of instruments is targeted at three therapeutic endoscopic specialties: lower GI; lung/bronchoscopy and upper GI.


Sector: Healthcare
Industry: Medical Devices
Keywords: Energy Gas Medicine Pipe Radio Cancer Medical Device IPO Surgery Microwave Lung Cancer

Is CREO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 243.0
52 Week Low 135.155
Average Volume 33,035
200-Day Moving Average 190.46
50-Day Moving Average 212.17
20-Day Moving Average 204.23
10-Day Moving Average 201.45
Average True Range 9.05
ADX 18.74
+DI 5.49
-DI 11.87
Chandelier Exit (Long, 3 ATRs ) 186.85
Chandelier Exit (Short, 3 ATRs ) 216.15
Upper Bollinger Band 214.42
Lower Bollinger Band 194.03
Percent B (%b) 0.22
BandWidth 9.98
MACD Line -3.55
MACD Signal Line -3.25
MACD Histogram -0.297
Fundamentals Value
Market Cap 313.41 Million
Num Shares 158 Million
EPS -12.10
Price-to-Earnings (P/E) Ratio -16.40
Price-to-Sales 28566.60
Price-to-Book 3.58
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 199.25
Resistance 3 (R3) 199.17 198.83 199.13
Resistance 2 (R2) 198.83 198.64 198.88 199.08
Resistance 1 (R1) 198.67 198.52 198.75 198.75 199.04
Pivot Point 198.33 198.33 198.38 198.38 198.33
Support 1 (S1) 198.17 198.14 198.25 198.25 197.96
Support 2 (S2) 197.83 198.02 197.88 197.92
Support 3 (S3) 197.67 197.83 197.88
Support 4 (S4) 197.75